Need Help? Call 1­-866-­796-­7386
« back to stock screener

  PRPH stock: ProPhase Labs Inc

Current Rating
Strong Buy

Previous Rating:

Strong Buy
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$1.88
Market Cap
36.2M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
6.5
P/S
1.85
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-500
FCF
0.0
Op. Margin
-12.70%
Net Margin
-13.60%
ROE
-43.50%
ROI
-35.40%
ROA
-22.70%
EPS Growth
24.30%
Current Ratio
1.4
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Kindred Healthcare, Inc. (KND) $8.90 - 5.70% 727.8M Strong Buy
Nephros, Inc. (NEPH) $0.36 - - 18.8M Strong Buy
Oramed Pharmaceuticals, Inc. (ORMP) $6.93 - - 81.4M Strong Buy
Daxor Corporation (DXR) $7.20 - 0.40% 28.3M Strong Buy
Pernix Therapeutics Holdings I (PTX) $3.88 - - 37.1M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More